NaturalShrimp, Inc. Closes $3,000,000 Registered Direct

Dallas, Texas, June 29, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — NaturalShrimp, Inc. (OTCQB: SHMP), a Biotechnology Aquaculture Company that has developed and patented the first shrimp-focused commercially operational RAS (Recirculating Aquaculture System), announced today that it has closed a registered direct offering of 7,500,000 shares of the Company’s common stock for gross proceeds of $3,000,000 pursuant to an effective shelf registration statement on Form S-3. The investor purchased the shares at a fixed price of $0.40 per share. This brings the total raised under the S-3 to $18M at an average price of $.525/share.

The Company intends to use the proceeds in connection with transactions related to previously announced letters of intent and plant expansions and retrofits at its NaturalShrimp Iowa location.

The securities (including warrants to purchase 1,100,000 shares of common stock at an exercise price of $0.01) were offered pursuant to an effective shelf registration statement (333-253953) that the Company previously filed with the Securities and Exchange Commission (“SEC”), which became effective on March 22, 2021. Final prospectus supplements relating to, and describing the terms of, the registered direct offering will be filed with the SEC shortly and will be available on the SEC’s website at www.sec.gov.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sales of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or other jurisdiction.

About NaturalShrimp

NaturalShrimp, Inc. is a publicly traded aquaculture Company, headquartered in Dallas, with production facilities located near San Antonio, Texas and Webster City, Iowa. The Company has developed the first commercially viable system for growing shrimp in enclosed, salt-water systems, using patented technology to produce fresh, never frozen, naturally grown shrimp, without the use of antibiotics or toxic chemicals. NaturalShrimp systems can be located anywhere in the world to produce gourmet-grade Pacific white shrimp. For more information visit www.naturalshrimp.com.

Forward Looking Statements

This press release contains “forward-looking statements.” The statements contained in this press release that are not purely historical are forward-looking statements. Forward-looking statements give the Company’s current expectations or forecasts of future events. Such statements are subject to risks and uncertainties that are often difficult to predict and beyond the Company’s control and could cause the Company’s results to differ materially from those described. In some cases, forward-looking statements can be identified by terminology such as “may,” “should,” “potential,” “continue,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” and similar expressions. These statements include statements regarding moving forward with executing the Company’s global growth strategy. The statements are based upon current beliefs, expectations, and assumptions and are subject to a number of risks and uncertainties, many of which are difficult to predict. The Company is providing this information as of the date of this press release and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise, except as required by law. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends affecting the financial condition of our business. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Important factors that could cause such differences include but are not limited to the Risk Factors and other information set forth in the Company’s Annual Report on Form 10-K filed on June 26, 2020, and in our other filings with the U.S. Securities and Exchange Commission.

Investor Relations Contact

Chris Tyson
Executive Vice President
MZ North America
Direct: 949-491-8235
[email protected]
www.mzgroup.us

Leave a Reply

Your email address will not be published. Required fields are marked *